Endocrine Carcinoma — Trials

Endocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 574
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +1.5%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (236)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06277180	68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC	recruiting	N/A	50	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Feb 26, 2024	clinicaltrials
NCT06271044	a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS	active not recruiting	N/A	61	Helsinki University Central HospitalOTHER	0	Feb 21, 2024	clinicaltrials